FI913067L - Bisfosfonsyraderivat, deras framstaellning och anvaendning. - Google Patents

Bisfosfonsyraderivat, deras framstaellning och anvaendning. Download PDF

Info

Publication number
FI913067L
FI913067L FI913067A FI913067A FI913067L FI 913067 L FI913067 L FI 913067L FI 913067 A FI913067 A FI 913067A FI 913067 A FI913067 A FI 913067A FI 913067 L FI913067 L FI 913067L
Authority
FI
Finland
Prior art keywords
bisphosphonsy
derivatives
deras framstaellning
framstaellning och
och anvaendning
Prior art date
Application number
FI913067A
Other languages
English (en)
Finnish (fi)
Other versions
FI913067A7 (fi
FI913067A0 (fi
Inventor
Takashi Sohda
Iwao Yamazaki
Noriaki Kawamura
Shigehisa Taketomi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI913067A0 publication Critical patent/FI913067A0/fi
Publication of FI913067A7 publication Critical patent/FI913067A7/fi
Publication of FI913067L publication Critical patent/FI913067L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
FI913067A 1990-06-25 1991-06-24 Bisfosfonsyraderivat, deras framstaellning och anvaendning. FI913067L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16760090 1990-06-25
JP41050190 1990-12-12
JP9208091 1991-04-23

Publications (3)

Publication Number Publication Date
FI913067A0 FI913067A0 (fi) 1991-06-24
FI913067A7 FI913067A7 (fi) 1991-12-26
FI913067L true FI913067L (fi) 1991-12-26

Family

ID=27306931

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913067A FI913067L (fi) 1990-06-25 1991-06-24 Bisfosfonsyraderivat, deras framstaellning och anvaendning.

Country Status (13)

Country Link
US (2) US5376647A (fr)
EP (1) EP0464509B1 (fr)
JP (1) JP3072390B2 (fr)
KR (1) KR920000778A (fr)
CN (1) CN1057654A (fr)
AT (1) ATE127123T1 (fr)
AU (1) AU637508B2 (fr)
CA (1) CA2045293A1 (fr)
DE (1) DE69112511T2 (fr)
FI (1) FI913067L (fr)
HU (1) HUT57787A (fr)
IE (1) IE912115A1 (fr)
NO (1) NO912462L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096061T3 (es) * 1991-08-27 1997-03-01 Ciba Geigy Ag Acidos aminometanodifosfonicos n-substituidos.
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
ES2239774T3 (es) * 1995-09-29 2005-10-01 Novartis Ag Metodo de tratamiento de la enfermedad navicular en caballos.
PL205637B1 (pl) * 2004-10-22 2010-05-31 Inst Farmaceutyczny Sposób wytwarzania kwasu (R,E)-(1-{1-{3-[2-(7-chlorochinolin-2-ylo)etenylo]fenylo}-3-[2-(1-hydroksy-1-metyloetylo)fenylo] propylosulfanylometylo}cyklopropylo)octowego i/lub jego farmaceutycznie dopuszczalnych soli
PL205444B1 (pl) * 2007-05-02 2010-04-30 Zak & Lstrok Ady Farmaceutyczn Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
CA2769633C (fr) * 2009-07-31 2017-06-06 Thar Pharma, Llc Procede de cristallisation et biodisponibilite
NZ599323A (en) 2009-10-15 2014-06-27 Univ Monash Affinity ligands and methods for protein purification
WO2012071517A2 (fr) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Nouvelles formes cristallines
WO2017208070A1 (fr) 2016-05-31 2017-12-07 Grünenthal GmbH Acide bisphosphonique et coformeurs avec lysine, glycine, nicotinamide pour le traitement de la polyarthrite psoriasique
US10865220B2 (en) 2016-06-03 2020-12-15 Biovinc, Llc Bisphosphonate quinolone conjugates and uses thereof
WO2017210611A1 (fr) * 2016-06-03 2017-12-07 Biovinc, Llc. Conjugués de bisphosphonate quinolone et leurs utilisations
CN119798509B (zh) * 2025-03-13 2025-08-26 西安蓝深新材料科技股份有限公司 一种锂提取用树脂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU445675A1 (ru) * 1972-12-28 1974-10-05 Казанский государственный университет им. В.И.Ульянова-Ленина Способ получени =фениламинотетралкилдифосфонметана
NL7613779A (nl) * 1975-12-16 1977-06-20 Hoechst Ag Werkwijze voor het bereiden van fosfor bevat- tende polyadducten.
JPS5437829A (en) * 1977-08-29 1979-03-20 Nissan Chem Ind Ltd Disulfonic acid type herbicidal and insecticidal agents
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
FR2558837B1 (fr) * 1984-01-26 1986-06-27 Sanofi Sa Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates
DE3770982D1 (de) * 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
EP0282309A3 (fr) * 1987-03-11 1990-03-14 Yamanouchi Pharmaceutical Co. Ltd. Dérivés de l'acide azole-aminométhylène-biphosphonique
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
CA1339805C (fr) * 1988-01-20 1998-04-07 Yasuo Isomura Acide (cycloalkylamino) methylenebis phosphonique et medicaments le contenant comme ingredients actif
JPH01258695A (ja) * 1988-04-07 1989-10-16 Yamanouchi Pharmaceut Co Ltd （ピラゾリルアミノ）メチレンビス（ホスホン酸）誘導体及びその医薬
US4933472A (en) * 1988-04-08 1990-06-12 Yamanouchi Pharmaceutical Co., Ltd. Substituted aminomethylenebis(phosphonic acid) derivatives
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids

Also Published As

Publication number Publication date
CN1057654A (zh) 1992-01-08
IE912115A1 (en) 1992-01-01
AU637508B2 (en) 1993-05-27
NO912462L (no) 1991-12-27
DE69112511D1 (de) 1995-10-05
JP3072390B2 (ja) 2000-07-31
FI913067A7 (fi) 1991-12-26
EP0464509B1 (fr) 1995-08-30
US5512552A (en) 1996-04-30
EP0464509A1 (fr) 1992-01-08
NO912462D0 (no) 1991-06-24
US5376647A (en) 1994-12-27
KR920000778A (ko) 1992-01-29
DE69112511T2 (de) 1996-02-08
CA2045293A1 (fr) 1991-12-26
JPH05294979A (ja) 1993-11-09
HUT57787A (en) 1991-12-30
ATE127123T1 (de) 1995-09-15
AU7928791A (en) 1992-01-02
FI913067A0 (fi) 1991-06-24

Similar Documents

Publication Publication Date Title
FI911936A7 (fi) Bensimidazolderivat, deras framstaellning och anvaendning.
FI915136L (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
FI923526A7 (fi) Braennsystem foer braensle, foerfarande och dysorgan foer detsamma.
FI914961A7 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI911211L (fi) Romboedriskt kalciumkarbonat och accelererat, termiskt aoldringsfoerfarande foer framstaellning daerav.
FI912379A0 (fi) Eldfast, vattenbestaendigt och syrafast bindemedel.
FI913503A7 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI915488L (fi) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning.
FI911584L (fi) Substituerade azoler, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI923548L (fi) Skumbildande komposition foer farmaceutisk anvaendning, anvaendning daerav och behandlingsmetod.
FI910311A0 (fi) Kalorifattiga, icke-kariogena aetbara kompositioner och foerfarande foer deras framstaellning.
FI913775A0 (fi) I 17-staellning substituerade korikoid-17-alkylkarbonater, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
FI913983L (fi) Svampmotverkande triazolderivat, deras framstaellning och anvaendningar.
FI910440A0 (fi) Alkenylgrupper innehaollande siloxankopolymerer, deras framstaellning och anvaendning.
FI913067L (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
FI914182A0 (fi) Maetningsfoerfarande foer magnetfaelt, maetningsapparat foer magnetfaelt, visningsfoerfarande foer magnetfaelt och visningsapparat foer magnetfaelt.
FI923492L (fi) Indolderivat, deras framstaellning och anvaendning.
FI912223L (fi) Katalytkompositioner och polymeriseringsfoerfarande, hexakisfosfiner och hexahalogenfoereningar.
FI914525L (fi) Foerening, anvaendning och framstaellning.
FI914114L (fi) Jodinerade, icke-joniserade foereningar, foerfarande foer deras framstaellning och dessa innehaollande kontrastmedel.
FI903951A7 (fi) Foerfarande framstaellning, och anordning foer foerverkligande av foerfarandet.
FI902611L (fi) Arkivlaoda foer loesa dokument, magasin och prosyrer.
FI904542A7 (fi) Kopplingsfotsystem foer ytfogningskomponenter, ytfogningskomponent och monteringsfoerfarande foer dessa.
FI915024L (fi) Oasomyciner, foerfarande foer deras framstaellning och deras anvaendning.
FI913419A7 (fi) Anordning foer maetning av toejningar, sammandragningar och motsvarande krafter i laengdsfoeraenderliga konstruktions- eller maskindelar.

Legal Events

Date Code Title Description
FD Application lapsed